Search

Viatris Inc

Закрыт

СекторЗдравоохранение

16.23 1.18

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

15.85

Макс.

16.26

Ключевые показатели

By Trading Economics

Доход

-295M

-119M

Продажи

240M

3.8B

Прибыль на акцию

0.69

Дивидендная доходность

2.92

Рентабельность продаж

-3.162

Сотрудники

30,000

EBITDA

9.4M

653M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+13.28% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

2.92%

2.22%

Следующий отчет о доходах

5 нояб. 2026 г.

Дата следующей выплаты дивидендов

16 сент. 2026 г.

Следующая эксдивидендная дата

21 авг. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.8B

19B

Предыдущая цена открытия

15.05

Предыдущая цена закрытия

16.23

Новостные настроения

By Acuity

50%

50%

163 / 340 Рейтинг в Healthcare

Viatris Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 авг. 2026 г., 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

13 авг. 2026 г., 20:06 UTC

Viatris Inc shares are lower today, reflecting broader market trends amid rising U.S. jobless claims that exceeded expectations. The stock remains near its one-month range low.

12 авг. 2026 г., 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

11 авг. 2026 г., 23:41 UTC

Viatris Inc. shares rose in after-market trading, despite earlier fluctuations and broader market concerns about inflationary pressures and oil prices.

10 авг. 2026 г., 19:42 UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7 авг. 2026 г., 22:01 UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

6 авг. 2026 г., 23:01 UTC

Viatris Inc shares are higher in after-market hours, recovering from earlier lows. The stock is trading above Thursday's close despite recent declines.

5 авг. 2026 г., 23:11 UTC

Viatris Inc. shares are trading higher in after-market hours, recovering significantly above the 20-day moving average amid broader market optimism despite no specific news.

4 авг. 2026 г., 23:06 UTC

Viatris Inc shares are higher in after-market trading, reflecting positive momentum and positioning above the 20-day moving average. No specific news was identified.

3 авг. 2026 г., 20:06 UTC

Viatris Inc shares are higher today, reflecting broader market gains led by major stocks. The S&P 500 and Nasdaq 100 have also risen.

31 июл. 2026 г., 21:02 UTC

Viatris Inc shares are lower in after-market hours, continuing a four-session decline amid rising inflation concerns and higher crude oil prices.

30 июл. 2026 г., 18:56 UTC

Event

Viatris shares are trading lower despite FDA approval of the Gwyn Lo contraceptive patch. Broader economic data may be impacting the stock's performance.

29 июл. 2026 г., 22:03 UTC

Event

Viatris Inc. shares are lower in after-market hours despite FDA approval of the Gwyn Lo contraceptive patch, amid broader market caution over geopolitical tensions.

28 июл. 2026 г., 19:36 UTC

Social Media

Viatris shares are higher today, supported by strong sector gains and a significant rise in January 2027 $10 call options activity.

27 июл. 2026 г., 19:11 UTC

Viatris Inc shares are higher today, breaking a trend of daily gains. No specific news was identified to explain this movement.

23 июл. 2026 г., 20:06 UTC

Viatris Inc's shares are higher during Thursday's session, continuing an upward trend since Wednesday's close. No specific news was identified to explain the movement.

22 июл. 2026 г., 23:16 UTC

Viatris Inc shares are higher in after-market hours, recovering from an earlier dip and reflecting strength amid rising crude oil prices.

21 июл. 2026 г., 18:46 UTC

Viatris Inc shares are higher today, rebounding after an earlier dip amid a broader recovery in U.S. markets and renewed investor optimism.

20 июл. 2026 г., 19:21 UTC

News

Viatris Inc shares are lower amid negative sentiment in the Pharmaceuticals sector. Analysts cite a price target of $17.81, reflecting concerns over sales declines.

Сравнение c конкурентами

Изменение цены

Viatris Inc Прогноз

Целевая цена

By TipRanks

13.28% рост

Прогноз на 12 месяцев

Средняя 18.17 USD  13.28%

Максимум 23 USD

Минимум 12 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для Viatris Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

6 ratings

2

Покупка

3

Удержание

1

Продажа

Настроения

By Acuity

163 / 340Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat